Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Inventory (2016 - 2025)

China Pharma Holdings' Inventory history spans 16 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Inventory fell 2.59% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $2.8 million, down 2.59%, while the annual FY2025 figure was $2.8 million, 2.59% down from the prior year.
  • Inventory reached $2.8 million in Q4 2025 per CPHI's latest filing, up from $1.6 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $3.9 million in Q2 2023 to a low of $1.6 million in Q3 2025.
  • Average Inventory over 5 years is $3.1 million, with a median of $3.0 million recorded in 2021.
  • Peak YoY movement for Inventory: soared 248.77% in 2021, then crashed 46.21% in 2025.
  • A 5-year view of Inventory shows it stood at $2.9 million in 2021, then changed by 0.0% to $2.9 million in 2022, then grew by 26.62% to $3.7 million in 2023, then fell by 23.91% to $2.8 million in 2024, then dropped by 2.59% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Inventory are $2.8 million (Q4 2025), $1.6 million (Q3 2025), and $2.7 million (Q2 2025).